Clinical Trial Update: Effect of Three Different Doses of Oral Cholecalciferol on 25-Hydroxyvitamin D Changes Among Epilepsy Patients With Hypovitaminosis D [Phase 4]

View source ↗

Summary

A Phase 4 trial compared three oral doses of cholecalciferol (vitamin D3) and assessed changes in 25-hydroxyvitamin D in epilepsy patients with hypovitaminosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Cholecalciferol (Vitamin D3)

Snippet

Sponsor: Chulalongkorn University | Conditions: Epilepsy | Phase 4 | Status: COMPLETED